Bicara Therapeutics Inc.
BCAX· Nasdaq
Bicara Therapeutics Inc.
- Last sale
- Oct 2, 2026 · -3.08%
- Market cap
- $1.17B
- 66.17M shares
- Filings
- 261
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | $63,600,000 | reported | |
| FY 2023 | 2023-12-31 | $30,600,000 | reported |
Bicara Therapeutics Inc. · CIK 2023658 · Engraved from SEC EDGAR
